Clinical Trials
102 trialsLenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
RenJi Hospital
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
University of Washington
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
American Regent, Inc.
PANORAMA
Techsomed Medical Technologies LTD
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
Eureka Therapeutics Inc.
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC)
MODELS
UniversitĂ Vita-Salute San Raffaele
Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
LEO Pharma
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
LEO Pharma
ABT-888 and Temozolomide for Liver Cancer
Georgetown University
MYCHELANGELO I
Omega Therapeutics
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
M.D. Anderson Cancer Center
LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors
National Institutes of Health Clinical Center (CC)
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Pfizer
Ultrasound Monitoring of Abdominal Soft Tissue
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ablation Confirmation Study
Ethicon, Inc.
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours
Fusion Pharmaceuticals Inc.
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Canadian Cancer Trials Group
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
H. Lee Moffitt Cancer Center and Research Institute
CheckMate 76U
Bristol-Myers Squibb
SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
ABLATE
Imunon
ET-109
Eureka Therapeutics Inc.
Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
National Institutes of Health Clinical Center (CC)
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Washington University School of Medicine
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Big Ten Cancer Research Consortium
Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma
BTG International Inc.
PATRON
Cellxpert Biotechnology Corp.
Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections
Insel Gruppe AG, University Hospital Bern
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
Wake Forest University Health Sciences
EXALT
Milton S. Hershey Medical Center
ReDos HCC
SC Liver Research Consortium, LLC
A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
University of California, San Diego
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
New Mexico Cancer Research Alliance
High Dose Rate Brachyablation of Primary Liver Lesions
University of Texas Southwestern Medical Center
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
Nanobiotix
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib
Gachon University Gil Medical Center
TRENDY
Erasmus Medical Center
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Sirtex Medical
A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver
Indiana University
Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer
National Institutes of Health Clinical Center (CC)
ARMTICH
Assistance Publique - HĂ´pitaux de Paris
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
National Institutes of Health Clinical Center (CC)
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
Aeon Therapeutics (Shanghai) Co., Ltd.